BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
EGFR
,
Coagulation
,
HIV infection
,
Prostate
,
Biofuel
,
Tamoxifen
,
rs2300478
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
am6527
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
AM6527, a neutral CB1 receptor antagonist, suppresses opioid taking and seeking, as well as cocaine …
The neutral CB1 antagonist AM6527 reduces ethanol seeking, binge-like consumption, reinforcing, and …
Inverse agonism of cannabinoid CB1 receptors potentiates LiCl-induced nausea in the conditioned gapi…
Oral bioavailability of the novel cannabinoid CB1 antagonist AM6527: effects on food-reinforced beha…
Cannabinoid Antagonist Drug Discrimination in Nonhuman Primates.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for am6527
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ